Nog een studie met propionyl -l carnitine bij claudicatio patienten.
http://www.ncbi.nlm.nih.gov/pubmed/11382369
Am J Med. 2001 Jun 1;110(8):616-22.
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.
CONCLUSIONS: Propionyl-L-carnitine safely improved treadmill exercise performance and enhanced functional status in patients with claudication.
——————————————————————————————————————–
en nog eentje:
http://www.ncbi.nlm.nih.gov/pubmed/11528327
Med Sci Sports Exerc. 2001 Sep;33(9):1415-22.
Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease.
CONCLUSIONS: These preliminary data suggest that, in addition to walking performance, muscle strength can be increased in PAD patients after 4 wk of supplementation with propionyl-L-carnitine.
—————————————————————————————————————–
en nog eentje:
http://www.ncbi.nlm.nih.gov/pubmed/7594063
J Am Coll Cardiol. 1995 Nov 15;26(6):1411-6.
Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
CONCLUSIONS: Although the precise mode of therapeutic action requires clarification, propionyl-L-carnitine, at a dose of 1 to 2 g/day, appears to be effective and well tolerated, with minimal adverse effects.